Use of a multiple-enzyme/multiple-reagent assay system to quantify activity levels in samples containing mixtures of

Fred H Rasmussen1, Nolan Yeung, Laura Kiefer

  • 1BioZyme, Inc., Apex, North Carolina 27523, USA.

Biochemistry
|March 17, 2004
PubMed

Insights

A new assay system (MEMRAS) simultaneously measures matrix metalloproteinase (MMP) activity. This technique accurately quantifies MMPs like collagenase 3, a potential biomarker for osteoarthritis (OA).

Area of Science:

  • Biochemistry
  • Enzymology
  • Molecular Biology

Background:

  • Matrix metalloproteinases (MMPs) are enzymes implicated in diseases like osteoarthritis (OA) and rheumatoid arthritis (RA).
  • Accurate measurement of specific MMP activity is crucial for understanding disease mechanisms and identifying biomarkers.

Purpose of the Study:

  • To develop and validate a novel technique for simultaneously measuring the activity of multiple enzymes, focusing on MMPs.
  • To establish a method for quantifying collagenase 3 activity as a potential biomarker for OA.

Main Methods:

  • Introduction of the multiple-enzyme/multiple-reagent assay system (MEMRAS), utilizing substrates with varying selectivity profiles.
  • Mathematical analysis involving simultaneous solving of equations generated from reaction rate measurements (fluorescence change over time).
  • Development of highly selective substrates for collagenase 3 based on bacteriophage substrate-mapping experiments.

Main Results:

  • The MEMRAS technique successfully measured activity levels in mixtures of MMPs, including collagenase 3 and gelatinase A.
  • Developed collagenase 3-selective substrates demonstrated significant selectivity over other MMPs (e.g., 37,000-fold over stromelysin 1).

Conclusions:

  • MEMRAS provides a robust method for simultaneous MMP activity profiling.
  • The developed selective substrates hold promise for accurate collagenase 3 quantification and OA biomarker development.